<DOC>
	<DOC>NCT00135447</DOC>
	<brief_summary>The purpose of this study is to find out the frequency of the I50L substitution among patients experiencing treatment failure on an atazanavir-containing regimen.</brief_summary>
	<brief_title>A Study of Prevalence of the I50L Mutation When ATV Treated Patients Fail the Regimen</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Atazanavir containing antiretroviral regimen Confirmed virologic failure defined as either: 1. HIV RNA by PCR greater than or equal to 1000 copies/mL after achieving a value of &lt;400 copies/mL on at least 2 consecutive measurements or 2. HIV RNA greater than or equal to 1000 copies/mL after 24 weeks of continuous therapy At least 18 years old Unable to give informed consent Prisoners or subjects involuntarily incarcerated for treatment of psychiatric or physical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>